Baird Affirms Sarepta Therapeutics (SRPT) at 'Outperform'; Incrementally Positive on PTAB Decision (BMRN)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. FDX
3. ABBV
4. MU
5. META
6. SPY
7. ACN
8. BLZE
9. IBM
10. NKE

Go back to Baird Affirms Sarepta Therapeutics (SRPT) at 'Outperform'; Incrementally Positive on PTAB Decision (BMRN)
BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) Delayed: 56.50 --0 (-0%)
Previous Close $56.50    52 Week High $108.96 
Open $56.50    52 Week Low $62.12 
Day High $56.50    P/E N/A 
Day Low $56.50    EPS $-1.27 
Volume 99       

SAREPTA THERAP (NASDAQ: SRPT) Delayed: 17.26 --0 (-0%)
Previous Close $17.26    52 Week High $63.73 
Open $17.26    52 Week Low $8.00 
Day High $17.26    P/E N/A 
Day Low $17.26    EPS $-5.69 
Volume 776